TCMSP: a Database of Systems Pharmacology for Drug Discovery from Herbal Medicines

Overview

Journal J Cheminform

Publisher Biomed Central

Specialty Chemistry

Date 2014 Apr 17

PMID 24735618

Citations 1965

Authors

Jinlong Ru

Peng Li

Jinan Wang

Wei Zhou

Bohui Li

Chao Huang

Pidong Li

Zihu Guo

Weiyang Tao

Yinfeng Yang

Xue Xu

Yan Li

Yonghua Wang

Ling Yang

Affiliations

Soon will be listed here.

Abstract

Background: Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug targets, associated diseases and interaction networks, are urgently needed.

Description: The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases. Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability, blood-brain barrier and Lipinski's rule of five are provided for drug screening and evaluation. TCMSP also provides drug targets and diseases of each active compound, which can automatically establish the compound-target and target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the development of herbal medicines and to promote integration of modern medicine and traditional medicine for drug discovery and development.

Conclusions: The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP is freely available at http://sm.nwsuaf.edu.cn/lsp/tcmsp.php.

Citing Articles

Exploring the therapeutic potential of "Zhi-Zhen" formula for oxaliplatin resistance in colorectal cancer: an integrated study combining UPLC-QTOF-MS/MS, bioinformatics, network pharmacology, and experimental validation.

Li Y, Chen K, Li Q, Liu Q, Han H, Liu H Front Med (Lausanne). 2025; 12:1516307.

PMID: 40078400 PMC: 11897289. DOI: 10.3389/fmed.2025.1516307.

Revealing Lingonberry's Neuroprotective Potential in Alzheimer's Disease Through Network Pharmacology and Molecular Docking.

Li J, Wang M, Wang Y, Peng X, Lv G, Zheng T Int J Mol Sci. 2025; 26(5).

PMID: 40076984 PMC: 11899733. DOI: 10.3390/ijms26052363.

Therapeutic Mechanisms of Medicine Food Homology Plants in Alzheimer's Disease: Insights from Network Pharmacology, Machine Learning, and Molecular Docking.

Wen S, Han Y, Li Y, Zhan D Int J Mol Sci. 2025; 26(5).

PMID: 40076742 PMC: 11899993. DOI: 10.3390/ijms26052121.

Curcumol attenuates hyperproliferation and inflammatory response in a psoriatic HaCaT keratinocyte model by inhibiting the PI3K-Akt pathway and ameliorates skin lesions and inflammatory status in psoriasis-like mice.

Niu M, Li X, Li M, Chen F, Cao H, Liu Q Inflammopharmacology. 2025; .

PMID: 40063187 DOI: 10.1007/s10787-025-01708-y.

FoxO1 as a Hub in Immunosenescence Induced by Hepatocellular Carcinoma and the Effect of Yangyin Fuzheng Jiedu Prescription.

Xie Y, Yan F, Liu X, Yu L, Yan H, Shang Z Drug Des Devel Ther. 2025; 19:1543-1560.

PMID: 40061815 PMC: 11890352. DOI: 10.2147/DDDT.S492576.

References

Ma T, Tan C, Zhang H, Wang M, Ding W, Li S . Bridging the gap between traditional Chinese medicine and systems biology: the connection of Cold Syndrome and NEI network. Mol Biosyst. 2010; 6(4):613-9. DOI: 10.1039/b914024g. View

Liu J, Pei M, Zheng C, Li Y, Wang Y, Lu A . A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets. Evid Based Complement Alternat Med. 2013; 2013:938764. PMC: 3863530. DOI: 10.1155/2013/938764. View

Zhang L, Liu T, Wang X, Wang J, Li G, Li Y . Insight into the binding mode and the structural features of the pyrimidine derivatives as human A2A adenosine receptor antagonists. Biosystems. 2013; 115:13-22. DOI: 10.1016/j.biosystems.2013.04.003. View

Li X, Xu X, Wang J, Yu H, Wang X, Yang H . A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS One. 2012; 7(9):e43918. PMC: 3433480. DOI: 10.1371/journal.pone.0043918. View

Gaulton A, Bellis L, Bento A, Chambers J, Davies M, Hersey A . ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2011; 40(Database issue):D1100-7. PMC: 3245175. DOI: 10.1093/nar/gkr777. View

Chen C . TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS One. 2011; 6(1):e15939. PMC: 3017089. DOI: 10.1371/journal.pone.0015939. View

Ye H, Ye L, Kang H, Zhang D, Tao L, Tang K . HIT: linking herbal active ingredients to targets. Nucleic Acids Res. 2010; 39(Database issue):D1055-9. PMC: 3013727. DOI: 10.1093/nar/gkq1165. View

Tao W, Xu X, Wang X, Li B, Wang Y, Li Y . Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2012; 145(1):1-10. DOI: 10.1016/j.jep.2012.09.051. View

Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y . A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012; 13(6):6964-6982. PMC: 3397506. DOI: 10.3390/ijms13066964. View

10.

Assenov Y, Ramirez F, Schelhorn S, Lengauer T, Albrecht M . Computing topological parameters of biological networks. Bioinformatics. 2007; 24(2):282-4. DOI: 10.1093/bioinformatics/btm554. View

11.

Shen M, Tian S, Li Y, Li Q, Xu X, Wang J . Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines. J Cheminform. 2012; 4(1):31. PMC: 3538521. DOI: 10.1186/1758-2946-4-31. View

12.

Su X, Kong L, Lei X, Hu L, Ye M, Zou H . Biological fingerprinting analysis of traditional Chinese medicines with targeting ADME/Tox property for screening of bioactive compounds by chromatographic and MS methods. Mini Rev Med Chem. 2007; 7(1):87-98. DOI: 10.2174/138955707779317830. View

13.

Li Y, Han C, Wang J, Xiao W, Wang Z, Zhang J . Investigation into the mechanism of Eucommia ulmoides Oliv. based on a systems pharmacology approach. J Ethnopharmacol. 2013; 151(1):452-60. DOI: 10.1016/j.jep.2013.10.067. View

14.

Cheung F . TCM: Made in China. Nature. 2011; 480(7378):S82-3. DOI: 10.1038/480S82a. View

15.

Wang X, Xu X, Tao W, Li Y, Wang Y, Yang L . A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease. Evid Based Complement Alternat Med. 2012; 2012:519031. PMC: 3518963. DOI: 10.1155/2012/519031. View

16.

Gu J, Gui Y, Chen L, Yuan G, Xu X . CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology. J Cheminform. 2013; 5(1):51. PMC: 3878363. DOI: 10.1186/1758-2946-5-51. View

17.

Yao Y, Zhang X, Wang Z, Zheng C, Li P, Huang C . Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. J Ethnopharmacol. 2013; 150(2):619-38. DOI: 10.1016/j.jep.2013.09.018. View

18.

Lopes C, Franz M, Kazi F, Donaldson S, Morris Q, Bader G . Cytoscape Web: an interactive web-based network browser. Bioinformatics. 2010; 26(18):2347-8. PMC: 2935447. DOI: 10.1093/bioinformatics/btq430. View

19.

Liu H, Wang J, Zhou W, Wang Y, Yang L . Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. J Ethnopharmacol. 2013; 146(3):773-93. DOI: 10.1016/j.jep.2013.02.004. View

20.

Yu H, Chen J, Xu X, Li Y, Zhao H, Fang Y . A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data. PLoS One. 2012; 7(5):e37608. PMC: 3364341. DOI: 10.1371/journal.pone.0037608. View